2008
DOI: 10.1016/j.jim.2007.11.011
|View full text |Cite
|
Sign up to set email alerts
|

In vivo validation of signaling pathways regulating human monocyte chemotaxis

Abstract: Identification of novel signal transduction pathways regulating monocyte chemotaxis can indicate unique targets for preventive therapies for treatment of chronic inflammatory diseases. To aid in this endeavor we report conditions for optimal transfection of primary human monocytes coupled with a new model system for assessing their chemotactic activity in vivo. This method can be used as a tool to identify the relevant signal transduction pathways regulating human monocyte chemotaxis to MCP-1 in the complex in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2008
2008
2024
2024

Publication Types

Select...
6

Relationship

3
3

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 29 publications
(29 reference statements)
0
5
0
Order By: Relevance
“…The impaired in vivo migration of adoptively transferred mouse monocytes that contain either inactive PLA 2 (by AACOCF 3 ) or were rendered defi cient in PLA 2 by AS-ODN validates our in vitro observations ( 14 ) in a dynamic in vivo milieu. We now have adapted this in vivo assay to monitor human monocyte chemotaxis ( 48 ). Our reports show the importance of in vitro studies for identifi cation of potential signaling components.…”
Section: Discussionmentioning
confidence: 98%
“…The impaired in vivo migration of adoptively transferred mouse monocytes that contain either inactive PLA 2 (by AACOCF 3 ) or were rendered defi cient in PLA 2 by AS-ODN validates our in vitro observations ( 14 ) in a dynamic in vivo milieu. We now have adapted this in vivo assay to monitor human monocyte chemotaxis ( 48 ). Our reports show the importance of in vitro studies for identifi cation of potential signaling components.…”
Section: Discussionmentioning
confidence: 98%
“…Primary monocytes were either nucleofected with GFP-PKCb-wild type (WT) or GFP-PKCb-dominant negative (DN) using the method providing optimal transfection efficiency as described earlier (25) using Human Monocyte Nucleofector Solution (Amaxa, Gaithersburg, MD) and the program Y-01 (in monocyte nucleofector solution). The GFP-tagged PKCb WT (GFP-PKCb-WT, pBK-CMV-GFP-PKCbII) and the DN mutant form of PKCb (GFP-PKCb-DN, pBK-CMV-GFP-PKCbII K371R) employed in our experiments were previously reported (25) and were a kind gift from Y. Hannun (Medical University of South Carolina, Charleston, SC). After nucleofection, the monocytes were carefully transferred to six-well plates containing Human Monocyte Nucleofector medium and incubated for 48 h.…”
Section: Transfection Of Pkcb Wild Type and Dominant-negative Mutant Into Primary Monocytesmentioning
confidence: 99%
“…The adoptive transfer model system was performed using tagged mouse monocytes transferred to recipient animals. This model has also been used to monitor the trafficking of human monocytes in mice during peritonitis, and human monocytes were shown to traffic similarly to mouse monocytes (37). Therefore, this adoptive transfer model can be used to assess the relevance of a particular enzyme for regulating human monocyte chemotaxis.…”
Section: In Vivo Validationmentioning
confidence: 99%